← FDA DRUG APPROVALS

FDA ANDA · ANDA210634

HYDROXYZINE HYDROCHLORIDE

Sponsor: APOZEAL PHARMS

APPLICATION
ANDA210634
TYPE
ANDA
ORIGINAL APPROVAL
2019-02-26
LATEST ACTION
2019-02-26
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Prescription

Products

HYDROXYZINE HYDROCHLORIDEPrescription
HYDROXYZINE HYDROCHLORIDE 10MG/5ML · SYRUP · ORAL

Approval history

2019-02-26UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →